Sumbangan 15 hb September 2024 – 1 hb Oktober 2024 Mengenai pengumpulan sumbangan

New Rapid-acting Antidepressants

New Rapid-acting Antidepressants

Kenji Hashimoto (editor), Mario Manto (editor)
5.0 / 5.0
0 comments
Sukakah anda buku ini?
Bagaimana kualiti fail ini?
Muat turun buku untuk menilai kualitinya
Bagaimana kualiti fail yang dimuat turun?
This book discusses new candidates for rapid-acting antidepressants, such as (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3 antagonists and AMPA receptor agonists.  There are serious limitations to currently available antidepressants, such as delayed onset and low rates of efficacy.  The discovery that a single dose of ketamine, an NMDAR antagonist, can produce rapid antidepressant effects that are sustained has led to new research in this area.  In this volume, a variety of novel pharmaceutical treatments are examined.  This volume would be useful to both researchers and clinicians who work in the field of pharmacology, specifically CNS drug treatments.
Tahun:
2021
Penerbit:
Springer
Bahasa:
english
Halaman:
156
ISBN 10:
3030797899
ISBN 13:
9783030797898
Nama siri:
Contemporary Clinical Neuroscience
Fail:
PDF, 3.75 MB
IPFS:
CID , CID Blake2b
english, 2021
Baca dalam Talian
Penukaran menjadi sedang dijalankan
Penukaran menjadi gagal

Istilah utama